What type of study is this?

September 10, 2025Journal of Clinical MedicineOpen Access

Pars Plana Vitrectomy Combined with Anti-VEGF Injections as an Approach to Treat Proliferative Diabetic Retinopathy

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis improved visual acuity in patients with proliferative diabetic retinopathy, indicating benefits of anti-VEGF therapy.

Preoperative anti-VEGF therapy improved visual acuity significantly, achieving 0.24 logMAR compared to 0.37 in the control group.
Intraocular pressure was lower in the study group at 16.84 mmHg, highlighting potential safety in using anti-VEGF.
Surgical duration was reduced in the study group with an average of 47.62 minutes, compared to 50.05 minutes in controls.
Frequency of surgery-induced retinal breaks was significantly lower at 0.34 in the study group versus 0.56 in controls.

Leszczyński et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 10, 2025Journal of Clinical MedicineOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis improved visual acuity in patients with proliferative diabetic retinopathy, indicating benefits of anti-VEGF therapy.

Preoperative anti-VEGF therapy improved visual acuity significantly, achieving 0.24 logMAR compared to 0.37 in the control group.
Intraocular pressure was lower in the study group at 16.84 mmHg, highlighting potential safety in using anti-VEGF.
Surgical duration was reduced in the study group with an average of 47.62 minutes, compared to 50.05 minutes in controls.
Frequency of surgery-induced retinal breaks was significantly lower at 0.34 in the study group versus 0.56 in controls.

Leszczyński et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark